A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation) (clinicaltrials.gov) - Sep 30, 2026 - P1 | N=71 | Active, not recruiting | Sponsor: Boehringer Ingelheim | Trial completion date: Apr 2028 ➔ Apr 2027 | Trial primary completion date: Mar 2028 ➔ Mar 2027
Monotherapy • Trial completion date • Trial primary completion date • Lung Adenocarcinoma • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • KRAS
|